Juan Cruz Cigudosa

A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.

Ana Osorio, Javier Benitez, Ramon Diaz-Uriarte, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms

Marina Bibikova, Xabier Agirre, Reiner Siebert, 2009, PloS one.